We are offering leflunomide.
Leflunomide is an antirheumatic agent. Leflunomide is a derivative of isoxazole used for its immunosuppressive and anti-inflammatory properties. As a prodrug, leflunomide is converted to an active metabolite, a77 1726, which blocks dihydroorotate dehydrogenase, a key enzyme of de novo pyrimidine synthesis, thereby preventing the expansion of activated t lymphocytes. This agent also inhibits various protein tyrosine kinases, such as protein kinase c (pkc), thereby inhibiting cell proliferation.
synonyms: 5-methyl-n-[4-(trifluoromethyl) phenyl]-1, 2-oxazole-4-carboxamide
cas number: 75706-12-6, mol. Formula: c12h9f3n2o2, mol.weight: 270.21
leflunomide is off white crystalline solid. It is soluble in dmso (54 mgml at 25 °c), ethanol (54 mgml at 25 °c), and water (

We are offering leflunomide.
Leflunomide is an antirheumatic agent. Leflunomide is a derivative of isoxazole used for its immunosuppressive and anti-inflammatory properties. As a prodrug, leflunomide is converted to an active metabolite, a77 1726, which blocks dihydroorotate dehydrogenase, a key enzyme of de novo pyrimidine synthesis, thereby preventing the expansion of activated t lymphocytes. This agent also inhibits various protein tyrosine kinases, such as protein kinase c (pkc), thereby inhibiting cell proliferation.
synonyms: 5-methyl-n-[4-(trifluoromethyl) phenyl]-1, 2-oxazole-4-carboxamide
cas number: 75706-12-6, mol. Formula: c12h9f3n2o2, mol.weight: 270.21
leflunomide is off white crystalline solid. It is soluble in dmso (54 mgml at 25 °c), ethanol (54 mgml at 25 °c), and water (